Halozyme to Attend Goldman Sachs 45th Annual Global Healthcare Conference

SAN DIEGO, June 4, 2024 -- Halozyme Therapeutics (NASDAQ: HALO) has revealed that its president and CEO, Dr. Helen Torley, will be presenting at the 45th Annual Goldman Sachs Global Healthcare Conference. The presentation is set for Tuesday, June 11, at 6:20 a.m. PT / 9:20 a.m. ET.

The presentation by Dr. Torley will be accessible through a live audio webcast available in the Investor Relations section of Halozyme's website. The audio webcast will remain accessible for 90 days after the event for those who cannot attend the live session.

About Halozyme Therapeutics

Halozyme Therapeutics is a biopharmaceutical company dedicated to enhancing patient care and outcomes through innovative solutions. The company is best known for its ENHANZE® drug delivery technology, which employs the proprietary enzyme rHuPH20. This technology enables the subcutaneous delivery of injectable drugs and fluids, aiming to minimize the treatment burden for patients.

Halozyme’s ENHANZE® technology has been integrated into seven commercial products, impacting over 800,000 patients across more than 100 global markets. The company has formed partnerships with prominent pharmaceutical and biotechnology companies such as Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical, and Acumen Pharmaceuticals.

Beyond ENHANZE®, Halozyme is involved in the development, manufacturing, and commercialization of drug-device combination products. These products utilize advanced auto-injector technologies designed to enhance convenience, reliability, and patient comfort. Halozyme’s proprietary products include Hylenex® and XYOSTED®. The company also collaborates on commercial products and developmental programs with partners like Teva Pharmaceuticals and Idorsia Pharmaceuticals.

Halozyme's headquarters are located in San Diego, CA, with additional offices in Ewing, NJ, and Minnetonka, MN, where their operations facility is situated.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!